RAIN THERAPEUTICS INC

$13.78 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About RAIN THERAPEUTICS INC

Rain Therapeutics Inc. operates as a clinical stage biotechnology company. The Company develops and produces biomarker-driven small molecule therapeutics for patients with cancer and other related diseases. Rain Therapeutics serves customers worldwide.

Stock Analysis

last close $13.69
1-mo return 3.6%
3-mo return -28.7%
avg daily vol. 56.7T
52-week high 23.9
52-week low 11.57
market cap. $276M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 87.8%
baraka

Subscribe now for daily local and international financial news

Subscribe